EMAIL THIS PAGE TO A FRIEND
SML0939 Sigma-Aldrich

PFI-3

≥98% (HPLC)

Synonym: (E)-1-(2-Hydroxyphenyl)-3-((1R,4R)-5-(pyridin-2-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)prop-2-en-1-one

  • Empirical Formula (Hill Notation) C19H19N3O2

  • Molecular Weight 321.37

  •  PubChem Substance ID 329825619

Purchase

Properties

Related Categories Bioactive Small Molecule Alphabetical Index, Bioactive Small Molecules, Cell Biology, Cell Signaling and Neuroscience, Gene Regulation,
InChI Key   INAICWLVUAKEPB-QSTFCLMHSA-N
assay   ≥98% (HPLC)
form   powder
color   yellow to orange
solubility   DMSO: 10 mg/mL, clear
storage temp.   2-8°C

Description

Packaging

5, 25 mg in glass bottle

Biochem/physiol Actions

SMARCA4 (SWI/SNF related, Matrix associated, Actin dependent Regulator of Chromatin, subfamily A, member 4) is a transcriptional activator and is a component of the large ATP-dependent chromatin remodeling complex SWI/SNF, which is required for transcriptional activation of genes normally repressed by chromatin. SMARC4 (also known as BRG1) and the related protein SMARCA2 (also known as BRM) contain a bromodomain that is structurally similar to the PolyBromo1 (PB1) 5 bromodomain. PFI-3 is a selective chemical probe for SMARCA bromodomains that inhibits SMARCA2, SMARCA4 and PB1(5) bromodomains. For full characterization details, please visit the PFI-3 probe summary on the Structural Genomics Consortium (SGC) website.

To learn about other SGC chemical probes for epigenetic targets, visit sigma.com/sgc

Features and Benefits

PFI-3 is an epigenetic chemical probe available through a partnership between Sigma Life Science and the Structural Genomics Consortium (SGC). To learn more and view other SGC epigenetic probes, visit sigma.com/SGC.

This compound is a featured product for Gene Regulation research. Click here to discover more featured Gene Regulation products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

Safety & Documentation

Safety Information

RIDADR 
NONH for all modes of transport
WGK Germany 
3

Documents

Certificate of Analysis


Milli-Q® Water Purification Solutions
Protocols & Articles

Articles

Discover Bioactive Small Molecules for Gene Regulation

The loss of regulation of gene expression is a key component to many human disease states, including neurodegenerative disorders, autoimmune conditions and, most prominently, cancers. Regulation of g...
Keywords: Acetylations, Epigenetics, Gene expression, Genomics, Methylations, PAGE, Post translational modifications, Transcription

Related Products

related product

Product #

Description

Comments

Add to Cart

SML1279 LLY-507, ≥97% (HPLC)
SML1276 BAZ2-ICR, ≥98% (HPLC)
PZ0307 PFI-4, ≥98% (HPLC)
SML1408 (R)-PFI-2, ≥97% (HPLC)
SML1410 A-366, ≥98% (HPLC)
SML1486 NI-57, ≥98% (HPLC)
PZ0312 (S)-PFI-2 SGC epigenetic chemical probe
SML1534 I-BRD9, ≥98% (HPLC)
U4885 UNC0638 hydrate, ≥98% (HPLC) SGC epigenetic chemical probe
SML0067 IOX1, ≥97% (HPLC)
SML0352 PFI-1, ≥98% (HPLC) SGC epigenetic chemical probe
SML0652 IOX2, ≥98% (HPLC) SGC epigenetic chemical probe
SML0662 UNC1215, ≥98% (HPLC)
SML0701 GSK-J4, ≥98% (HPLC) SGC epigenetic chemical probe
SML0709 GSK-J1, ≥98% (HPLC)
SML0768 GSK2801, ≥98% (HPLC) SGC epigenetic chemical probe
SML0766 GSK343, ≥98% (HPLC)
SML0778 UNC1999, ≥98% (HPLC)
SML0974 (+/-)-JQ1, ≥98% (HPLC) SGC epigenetic chemical probe
SML0992 Bromosporine, ≥98% (HPLC) SGC epigenetic chemical probe
SML1037 UNC0642, ≥98% (HPLC)
SML1072 GSK-LSD1, ≥98% (HPLC) SGC epigenetic chemical probe
SML1107 SGC0946, ≥98% (HPLC)
SML1133 SGC-CBP30, ≥98% (HPLC) SGC epigenetic chemical probe
SML1134 I-CBP112, ≥98% (HPLC) SGC epigenetic chemical probe
SML1184 OF-1, ≥98% (HPLC) SGC epigenetic chemical probe
SML1209 OICR-9429, ≥98% (HPLC)
SML1242 SGC707, ≥98% (HPLC)

Technical Service:

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Bulk Ordering & Pricing:

Need larger quantities for your development, manufacturing or research applications?